Common side effects are nausea, vomiting, diarrhea, and constipation
Does not cover obesity medications, but covers Ozempic (semaglutide) when prescribed for type 2 diabetes
Both medications are generally safe when prescribed and monitored by a licensed physician
Key facts Kaiser NW requires maximum-tolerated metformin AND a documented SGLT-2 inhibitor trial before approving Ozempic for T2D the strictest step therapy of any insurer in the Ozempic cluster
Quantitative endpoints, such as MRI-PDFF and histology, can capture subtle yet clinically meaningful changes, whereas ALT/AST and ultrasonography may miss early metabolic improvements
Many patients are evaluated alongside structured metabolic programs like our Prediabetes Reversal Program in Chula Vista to improve A1C and reduce long-term medication dependence